Results 141 to 150 of about 5,801,283 (182)
PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study. [PDF]
Hepatol IntGao H +17 more
europepmc +1 more source
Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients. [PDF]
Intern Emerg MedMolfino A +10 more
europepmc +1 more source
[PIVKA-II as a serological marker of hepatocellular carcinoma].
The Korean journal of hepatology, 2008 openaire +1 more source
Perioperative changes in PIVKA-II
Scandinavian Journal of Clinical and Laboratory Investigation, 2015 Proteins induced by vitamin K absence for factor II (PIVKA-II) is an enzyme-linked immunosorbent assay that monitors uncarboxylated prothrombin and responds to vitamin K deficits prior to changes in the prothrombin test. The aim of this project was to study perioperative PIVKA-II changes during various types of surgery in a prospective observational ...
Ulf Schött +2 more
exaly +5 more sources
Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II [PDF]
Clinical Biochemistry, 2015 Protein induced by vitamin K absence or antagonist-II (PIVKA-II) has been used as a tumor marker to aid in the diagnosis of hepatocellular carcinoma (HCC). We developed an anti-PIVKA-II monoclonal antibody, 3C10, and a fully automated quantitative immunoassay for PIVKA-II on the ARCHITECT® i-systems.
Kinukawa, Hideki +2 more
exaly +4 more sources
Primary colon cancer with a high serum PIVKA-II level [PDF]
International Journal of Surgery Case Reports, 2015 IntroductionProtein induced by vitamin K absence/antagonist-II (PIVKA-II) is an abnormal protein, and several reports have demonstrated the efficacy of PIVKA-II in the diagnosis of hepatocellular carcinoma (HCC).
Kazuya Kato +2 more
exaly +2 more sources
Impact of PIVKA-II in diagnosis of hepatocellular carcinoma
Journal of Advanced Research, 2013 Liver cancer grows silently with mild or no symptoms until advanced. In the absence of an effective treatment for advanced stage of hepatic cancer hope lies in early detection, and screening for high-risk population. Among Egyptians viral hepatitis is the most common risk factor for hepatocellular carcinoma (HCC).
Hanan E Shafik
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
PIVKA-II-producing advanced gastric cancer
International Journal of Clinical Oncology, 2004We describe the case of a 68-year-old man with primary advanced adenocarcinoma of the stomach, who displayed extremely high plasma levels of protein induced by vitamin K antagonist (PIVKA)-II (15 600 mAU/ml) and normal levels of alphafetoprotein (AFP) (4 ng/ml). Ultrasonography and dynamic computed tomography ruled out hepatocellular carcinoma (HCC) or
Shigetsugu, Takano +7 more
openaire +2 more sources
A simple and rapid test for Pivka-II in plasma
Thrombosis Research, 1982A simple and rapid assay for the detection of PIVKA-II is described. The principle of the assay is based on agglutination of antihuman prothrombin rabbit IgG coated latex with absorbed plasma which is treated with barium carbonate. This assay is expected to be useful as a screening test to differentiate whether or not vitamin K deficiency is present in
T, Meguro, K, Yamada
openaire +2 more sources
International Journal of Legal Medicine, 2003
To date there is no routinely used reliable diagnostic test that can be performed in the post-mortem period to investigate whether a deceased had a coagulation disorder. This paper describes a series of experiments to assess the use of an antigen-based method to investigate the vitamin K-dependent factor II function in the deceased. It illustrates that
Rutty, G.N. +4 more
openaire +3 more sources
To date there is no routinely used reliable diagnostic test that can be performed in the post-mortem period to investigate whether a deceased had a coagulation disorder. This paper describes a series of experiments to assess the use of an antigen-based method to investigate the vitamin K-dependent factor II function in the deceased. It illustrates that
Rutty, G.N. +4 more
openaire +3 more sources